Abstract
Recently, we have reported that the protein 4.1B immunolocalization occurred only in matured columnar epithelial cells of normal rat intestines. This finding suggested that protein 4.1B expression could be examined for a possible change during neoplastic transformation of the intestinal mucosa. In the present study, we first present the distribution of mouse protein 4.1B in normal intestinal epithelial cells and tumor cells using the adenomatous polyposis coli (Apc) mutant mouse model. A low level of protein 4.1B expression coincided with the phenotypic transition to carcinoma. To examine the protein 4.1B expression in human intestinal mucosa, we used another antibody against an isoform of the human protein 4.1B, DAL-1 (differentially expressed adenocarcinoma of the lung). Human DAL-1 was also expressed in matured epithelial cells in human colons, with a definite expression gradient along the crypt axis. In human colorectal cancer cells, however, DAL-1 expression was not detected. These results suggest that mouse protein 4.1B and human DAL-1 might have a striking analogy of functions, which may be integrally involved in epithelial proliferation. We propose that loss of protein 4.1B/DAL-1 expression might be a marker of intestinal tumors, indicative of a tumor suppressor function in the intestinal mucosa.
Similar content being viewed by others
References
Baldin V (2000) 14-3-3 proteins and growth control. Prog Cell Cycle Res 4:49–60
Binda AV, Kabbani N, Lin R, Levenson R (2002) D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1 N. Mol Pharmacol 62:507–513
Braga VM (2002) Cell–cell adhesion and signaling. Curr Opin Cell Biol 14:546–556
Bright-Thomas RM, Hargest R (2003) APC, beta-catenin and hTCF-4: an unholy trinity in the genesis of colorectal cancer. Eur J Surg Oncol 29:107–117
Charboneau AL, Singh V, Yu T, Newsham IF (2002) Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells. Int J Cancer 100:181–188
Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low PS, Rouleau GA, Mohandas N, Chasis JA, Conboy JG, Gascard P, Takakuwa Y, Huang SC, Benz EJ Jr, Bretscher A, Fehon RG, Gusella JF, Ramesh V, Solomon F, Marchesi VT, Tsukita S, Tsukita S, Arpin M, Louvard D, Tonks NK, Anderson JM, Fanning AS, Bryant PJ, Woods DF, Hoover KB (1998) The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23:281–282
Cohen AR, Woods DF, Marfatia SM, Walther Z, Chishti AH, Anderson JM, Wood DF (1998) Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J Cell Biol 142:129–138
Conboy JG (1993) Structure, function, and molecular genetics of erythroid membrane skeletal protein 4.1 in normal and abnormal red blood cells. Semin Hematol 30:58–73
Crepaldi T, Gautreau A, Comoglio PM, Louvard D, Arpin M (1997) Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J Cell Biol 138:423–434
Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T, Yamakawa H, Ohara O, Carnaud M, Girault JA (2003) Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur J Neurosci 17:411–416
Fodde R, Smits R (2001) Disease model: familial adenomatous polyposis. Trends Mol Med 7:369–373
Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653:1–24
Gimm JA, An X, Nunomura W, Mohandas N (2002) Functional characterization of spectrin-actin-binding domains in 4.1 family of proteins. Biochemistry 41:7275–7282
Gollan L, Sabanay H, Poliak S, Berglund EO, Ranscht B, Peles E (2002) Retention of a cell adhesion complex at the paranodal junction requires the cytoplasmic region of Caspr. J Cell Biol 157:1247–1256
Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (2000) Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 9:1495–1500
Gutmann DH, Hirbe AC, Huang ZY, Haipek CA (2001) The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis 8:266–278
Hoover KB, Bryant PJ (2000) The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. Curr Opin Cell Biol 12:229–234
Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH (2000) Expression of b-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 21:1935–1940
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10:182–186
Kolligs FT, Bommer G, Goke B (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66:131–144
Krieg J, Hunter T (1992) Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 267:19258–19265
Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140:647–657
Muslin AJ, Xing H (2000) 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 12:703–709
Ohara R, Yamakawa H, Nakayama M, Ohara O (2000) Type II brain 4.1 (4.1B/KIAA0987), a member of the protein 4.1 family, is localized to neuronal paranodes. Brain Res Mol Brain Res 85:41–52
Parra M, Gascard P, Walensky LD, Gimm JA, Blackshaw S, Chan N, Takakuwa Y, Berger T, Lee G, Chasis JA, Snyder SH, Mohandas N, Conboy JG (2000) Molecular and functional characterization of protein 4.1B, a novel member of protein 4.1 family with high level, focal expression in brain. J Biol Chem 275:3247–3255
Perez-Moreno M, Jamora C, Fuchs E (2003) Sticky business: orchestrating cellular signals at adherens junctions. Cell 21:535–548
Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH (2000) Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 59:872–879
Perry A, Giannini C, Raghavan R, Scheithauer BW, Banerjee R, Margraf L, Bowers DC, Lytle RA, Newsham IF, Gutmann DH (2001) Aggressive phenotypic and genotypic features in pediatric and NF-2 associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 60:994–1003
Polakis P (2000) Wnt signaling and cancer. Genes Dev 14:1837–1851
Ramez M, Blot-Chabaud M, Cluzeaud F, Chanan S, Patterson M, Walensky LD, Marfatia S, Baines AJ, Chasis JA, Conboy JG, Mohandas N, Gascard P (2003) Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron. Kidney Int 63:1321–1337
Shen L, Liang F, Walensky LD, Huganir RL (2000) Regulation of AMPA receptor GluR1 subunit surface expression by a 4.1N-linked actin cytoskeletal association. J Neurosci 20:7932–7940
Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A (2002) Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Mod Pathol 15:526–531
Sloncova E, Fric P, Kucerova D, Lojda Z, Tuhackova Z, Sovova V (2001) Changes of E-cadherin and b-catenin in human and mouse intestinal tumours. Histochem J 33:13–17
Stewart BW, Kleihues P (2003) World cancer report. IARC Press, Lyon
Sun CX, Robb VA, Gutmann DH (2002) Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J Cell Sci 115:3991–4000
Takakuwa Y (2000) Protein 4.1, a multifunctional protein of the erythrocyte membrane skeleton: structure and functions in erythrocytes and nonerythroid cells. Int J Hematol 72:298–309
Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Christofori G, Ohara O, Ohno S (2003) Protein 4.1B in mouse islets of Langerhans and b-cell tumorigenesis. Histochem Cell Biol 120:277–283
Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Zea Z, Ohara O, Ohno S (2004a) Immunohistochemical study of protein 4.1B in the normal and W/Wv mouse seminiferous epithelium. J Histochem Cytochem 52:769–777
Terada N, Ohno N, Yamakawa H, Seki G, Fujii Y, Baba T, Ohara O, Ohno S (2004b) Immunoelectron microscopic localization of protein 4.1B in proximal S1 and S2 tubules of rodent kidneys. Med Electron Microsc 37:45–51
Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Ohara O, Ohno S (2004c) Immunolocalization of protein 4.1B in the rat digestive system. J Mol Histol 35:347–353
Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Ohara O, Ohno S (2004d) Protein 4.1B localizes on unmyelinated axonal membranes in the mouse enteric nervous system. Neurosci Lett 366:15–17
Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, Newsham IF (1999) A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res 59:35–43
Tran Quang C, Gautreau A, Arpin M, Treisman R (2000) Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. EMBO J 19:4565–4576
Walensky LD, Gascard P, Fields ME, Blackshaw S, Conboy JG, Mohandas N, Snyder SH (1998) The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. J Cell Biol 141:143–153
Walensky LD, Blackshaw S, Liao D, Watkins CC, Weier HG, Parra M, Huganir RL, Conboy JG, Mohandas N, Snyder SH (1999) A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1. J Neurosci 19:6457–6467
Wong NA, Pignatelli M (2002) Beta-catenin: a linchpin in colorectal carcinogenesis? Am J Pathol 160:389–401
Yamakawa H, Ohara O (2000) Comparison of mRNA and protein levels of four members of the protein 4.1 family: the type II brain 4.1/4.1B/KIAA0987 is the most predominant member of the protein 4.1 family in rat brain. Gene 248:137–145
Yamakawa H, Ohara R, Nakajima D, Nakayama M, Ohara O (1999) Molecular characterization of a new member of the protein 4.1 family (brain 4.1) in rat brain. Brain Res Mol Brain Res 70:197–209
Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF (2002) The 4.1/ezrin/radixin/moesin domain of the DAL-1/protein 4.1B tumour suppressor interacts with 14-3-3 proteins. Biochem J 365:783–789
Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10:175–181
Zhang S, Mizutani A, Hisatsune C, Higo T, Bannai H, Nakayama T, Hattori M, Mikoshiba K (2003) Protein 4.1 N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells. J Biol Chem 278:4048–4056
Acknowledgements
The authors would like to thank Dr. Riccardo Fodde, Department of Pathology, Josephone Nefkens Institute, Erasmus University Medical Center, for sending us the intestinal tissues of Apc mutant model mouse, Apc+/Apc1638 N. The authors also thank Drs. Takeshi Baba, Yasuhisa Fujii, and Zagreb Zea-Aragon, Department of Anatomy, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, for their constructive comments on this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ohno, N., Terada, N., Murata, Si. et al. Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium. Histochem Cell Biol 122, 579–586 (2004). https://doi.org/10.1007/s00418-004-0716-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-004-0716-7